> Detailanzeige

Tilburt, Jon C.; Zahrieh, David; Pacyna, Joel E.; Petereit, Daniel G.; Kaur, Judith S.; Rapkin, Bruce D.; Grubb, Robert L.; Chang, George J.; Morris, Michael J.; Kovac, Evan Z.; Babaian, Kara N.; Sloan, Jeff A.; Basch, Ethan M.; Peil, Elizabeth S.; Dueck, Amylou C.; Novotny, Paul J.; Paskett, Electra D.; Buckner, Jan C.; Joyce, Daniel D.; Montori, Victor M.; Frosch, Dominick L.; Volk, Robert J.; Kim, Simon P.

Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD)

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD)
  • Beteiligte: Tilburt, Jon C.; Zahrieh, David; Pacyna, Joel E.; Petereit, Daniel G.; Kaur, Judith S.; Rapkin, Bruce D.; Grubb, Robert L.; Chang, George J.; Morris, Michael J.; Kovac, Evan Z.; Babaian, Kara N.; Sloan, Jeff A.; Basch, Ethan M.; Peil, Elizabeth S.; Dueck, Amylou C.; Novotny, Paul J.; Paskett, Electra D.; Buckner, Jan C.; Joyce, Daniel D.; Montori, Victor M.; Frosch, Dominick L.; Volk, Robert J.; Kim, Simon P.
  • Erschienen: Wiley, 2022
  • Erschienen in: Cancer
  • Sprache: Englisch
  • DOI: 10.1002/cncr.34062
  • ISSN: 0008-543X; 1097-0142
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:sec><jats:title>Background</jats:title><jats:p>Decision aids (DAs) can improve knowledge for prostate cancer treatment. However, the relative effects of DAs delivered within the clinical encounter and in more diverse patient populations are unknown. A multicenter cluster randomized controlled trial with a 2×2 factorial design was performed to test the effectiveness of within‐visit and previsit DAs for localized prostate cancer, and minority men were oversampled.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The interventions were delivered in urology practices affiliated with the NCI Community Oncology Research Program Alliance Research Base. The primary outcome was prostate cancer knowledge (percent correct on a 12‐item measure) assessed immediately after a urology consultation.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Four sites administered the previsit DA (39 patients), 4 sites administered the within‐visit DA (44 patients), 3 sites administered both previsit and within‐visit DAs (25 patients), and 4 sites provided usual care (50 patients). The median percent correct in prostate cancer knowledge, based on the postvisit knowledge assessment after the intervention delivery, was as follows: 75% for the pre+within‐visit DA study arm, 67% for the previsit DA only arm, 58% for the within‐visit DA only arm, and 58% for the usual‐care arm. Neither the previsit DA nor the within‐visit DA had a significant impact on patient knowledge of prostate cancer treatments at the prespecified 2.5% significance level (<jats:italic>P</jats:italic> = .132 and <jats:italic>P</jats:italic> = .977, respectively).</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>DAs for localized prostate cancer treatment provided at 2 different points in the care continuum in a trial that oversampled minority men did not confer measurable gains in prostate cancer knowledge.</jats:p></jats:sec>
  • Zugangsstatus: Freier Zugang